ICR to study fadraciclib to treat paediatric neuroblastoma

The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma.

Read more: https://www.clinicaltrialsarena.com/news/icr-fadraciclib-neuroblastoma/